ResMed (RMD) r&d spend was $378M in FY2026 (+14% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2026
$378M
+14%
2025
$331M
+8%
2024
$308M
+7%
2023
$288M
+13%
2022
$254M
+13%
2021
$225M
+12%
2020
$202M
+12%
2019
$181M
+16%
2018
$155M
+7%
2017
$144M
+22%
2016
$119M
+3%
2015
$115M
-3%
2014
$118M
-2%
2013
$120M
+9%
2012
$110M
+19%
2011
$92M
+22%
2010
$75M
+19%
2009
$63M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$106M
Q1 2026
$94M
Q4 2025
$91M
Q3 2025
$87M
Q2 2025
$86M
Q1 2025
$84M
Q4 2024
$81M
Q3 2024
$80M
Q2 2024
$81M
Q1 2024
$77M
Q4 2023
$74M
Q3 2023
$76M
Source: RMD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.